论文信息 - 1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTS - 字舞流文

1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTS

D. Stefanidis | L. Webster | T. Marbury | P. German | E. Lawitz | A. Ray | S. Arterburn | J. Hill | D. Gruener | S. Rossi | L. Hazan | M. Rodríguez-Torres | R. Morrison | R. Majuskas | M. DiMcco | E. Svaroskaia | A. Jain | J. McHutchson